148
BEIGI‐SOMAR ET AL.
3
3
H, d, J = 7.2 Hz, 2 CH), 7.25 (2 H, d, J = 7.2 Hz, CH),
(CH), 114.2 (CH), 127.3 (CH), 128.2 (2 CH), 129.7 (2
3
7
.28–7.40 (5 H, m, 5 CH), 7.63 (2 H, d, J = 7.7 Hz, 2
CH), 7.80 (2 H, d, J = 7.1 Hz, 2 CH). C NMR
CH), 134.8 (C), 150.1 (C), 167.8 (C). EI‐MS (70 eV): m/z
3
13
+
(%) = 245 (M , 1), 230 (9), 202 (17), 126 (34), 112 (63),
(
125.7 MHz, CDCl ): δ = 23.5 (Me), 66.1 (CH), 79.3
98 (84), 77 (100). Anal. Calcd (%) for C H NO
2
3
C
15 19
(
CH ), 115.2 (CH), 126.3 (2 CH), 127.1 (CH), 127.5 (2
(245.32): C, 73.44, H, 7.81, N, 5.71. Found: C, 73. 62, H,
7.95, N, 5.87.
2
CH), 127.9 (CH), 128.2 (2 CH), 128.9 (2 CH), 129.3 (2
CH), 130.8 (2 CH), 133.1 (C), 138.5 (C), 139.8 (C), 141.3
(
(
(
C), 147.2 (C), 166.2 (C). EI‐MS (70 eV): m/z (%) = 355
M , 2), 278 (9), 188 (36), 175 (57), 98 (87), 91 (42), 77
+
3.19 | 2‐Benzylidene‐4‐cyclohexyl‐6‐
methylmorpholin‐3‐one (4o)
100). Anal. Calcd (%) for C H NO (355.44): C, 80.10;
24
21
2
H, 5.96, N, 3.94. Found: C, 79.98; H, 5.82, N, 3.99.
The crude product was purified by column chromatogra-
phy (SiO ; Hexane/EtOAc 5/1, R : 0.35) affording 0.24 g
2
f
3
.17 | 2‐Benzylidene‐5‐(4‐bromophenyl)‐4‐
(84%) of 4o; Colorless solid, m.p: 82–84°C. IR (KBr): v =
1
phenylmorpholin‐3‐one (4 m)
3021, 2935, 1652, 1435, 1311, 1178, 1054. H NMR
3
(
500.1 MHz, CDCl ): δ = 1.27 (3 H, d, J = 6.3 Hz,
3
H
The crude product was purified by column chromatogra-
Me), 1.35–1.87 (10 H, m, 5 CH ), 3.52 (1 H, dd,
2
2
2
3
phy (SiO ; Hexane/EtOAc 3/1, R : 0.16) affording 0.39 g
J = 13.2 Hz, J = 10.1 Hz, CH), 3.65 (1 H, dd,
2
f
3
(
(
94%) of 4 m; Colorless solid, m.p: 100–102°C. IR
KBr): v = 3036, 2982, 1658, 1436, 1312, 1163, 1042. H
J = 13.2 Hz, J = 5.1 Hz, CH), 3.77–3.82 (1 H, m, CH),
1
4.61–4.67 (1 H, m, CH), 6.49 (1 H, s, CH), 7.32 (1 H, t,
3
3
NMR (500.1 MHz, CDCl ): δ = 4.81 (1 H, dd,
J = 7.8 Hz, CH), 7.48 (2 H, t, J = 7.8 Hz, 2 CH), 7.67
3
H
2
2
3
3
13
J = 13.4 Hz, J = 5.6 Hz, CH), 4.96 (1 H, dd,
J = 13.4 Hz, J = 9.5 Hz, CH), 5.22–5.26 (1 H, m,
CH), 6.64 (1 H, s, CH), 6.92 (1 H, t, J = 7.3 Hz, CH),
.19 (2 H, d, J = 7.6 Hz, 2 CH), 7.31 (2 H, t,
J = 7.3 Hz, CH), 7.37 (1 H, t, J = 7.8 Hz, CH), 7.45
2 H, d, J = 7.8 Hz, 2 CH), 7.66 (2 H, d, J = 7.8 Hz, 2
CH), 7.78 (2 H, d, J = 7.3 Hz, 2 CH), 7.91 (2 H, d,
J = 7.6 Hz, 2 CH). C NMR (125.7 MHz, CDCl3):
δ = 69.3 (CH), 80.1 (CH ), 115.7 (CH), 120.4 (C), 126.8
(2 H, d, J = 7.8 Hz, 2 CH). C NMR (125.7 MHz,
CDCl ): δ = 20.1 (Me), 24.1 (CH ), 27.3 (CH ), 29.4
3
3
C
2
2
3
(CH ), 30.8 (CH ), 36.6 (CH ), 53.5 (CH ), 66.8 (CH),
2 2 2 2
79.1 (CH), 115.5 (CH), 126.8 (CH), 128.7 (2 CH), 129.5
3
7
3
3
(2 CH), 134.1 (C), 150.6 (C), 168.6 (C). EI‐MS (70 eV):
3
3
+
(
m/z (%) = 285 (M , 3), 270 (12), 181 (34), 112 (47), 98
3
(83), 83 (71), 77 (100). Anal. Calcd (%) for C H NO
2
18
23
3
13
(285.39): C, 75.76, H, 8.12, N, 4.91. Found: C, 75. 91, H,
8.28, N, 5.12.
C
2
(2 CH), 127.3 (CH), 127.7 (2 CH), 128.5 (CH), 128.9 (2
CH), 129.7 (2 CH), 130.5 (2 CH), 132.7 (2 CH), 133.6
3
.20 | 6‐Methyl‐2‐(4‐methylbenzylidene)‐
(
(
3
C), 140.1 (C), 143.5 (C), 149.1 (C), 166.7 (C). EI‐MS
+
+
4‐phenylmorpholin‐3‐one (4p)
70 eV): m/z (%) = 421 (M , 4), 419 (M , 4), 332 (9),
30 (9), 254 (32), 252 (32), 175 (57), 98 (87), 91 (28), 77
100). Anal. Calcd (%) for C H BrNO (420.31): C,
The crude product was purified by column chromatogra-
phy (SiO ; Hexane/EtOAc 5/1, R : 0.36) affording 0.23 g
(
23
18
2
2
f
6
5.73; H, 4.32, N, 3.33. Found: C, 65.90; H, 4.50, N, 3.51.
(
80%) of 4p; Colorless solid, m.p: 81–83°C. IR (KBr): v =
1
3
018, 2971, 1647, 1445, 1278, 1106, 1032. H NMR
(500.1 MHz, CDCl ): δ = 1.33 (3 H, s, Me), 2.58 (3 H,
s, Me), 4.01 (1 H, dd, J = 12.8 Hz, J = 10.1 Hz, CH),
3
.18 | 2‐Benzylidene‐4‐isopropyl‐6‐
3
H
2
3
methylmorpholin‐3‐one (4n)
2
3
4.14 (1 H, dd, J = 12.8 Hz, J = 4.9 Hz, CH), 4.67–4.73
The crude product was purified by column chromatogra-
(1 H, m, CH), 6.61 (1 H, s, CH), 7.01 (1 H, t,
3
3
phy (SiO ; Hexane/EtOAc 6/1, R : 0.34) affording 0.21 g
J = 7.4 Hz, CH), 7.30 (2 H, t, J = 7.4 Hz, 2 CH), 7.46
2
f
3
3
(
1
83%) of 4n; Colorless oil. IR (KBr): v = 3011, 2935,
(2 H, d, J = 7.8 Hz, 2 CH), 7.65 (2 H, d, J = 7.8 Hz, 2
1
3
13
651, 1542, 1471, 1255, 1067. H NMR (500.1 MHz,
CH), 7.79 (2 H, d, J = 7.4 Hz, 2 CH). C NMR
(125.7 MHz, CDCl ): δ = 21.2 (Me), 24.3 (Me), 68.8
3
CDCl ): δ = 1.23 (6 H, d, J = 6.1 Hz, 2 Me), 1.34 (3
3
H
3
C
3
2
H, d, J = 6.2 Hz, Me), 3.41 (1 H, dd, J = 11.7 Hz,
(CH ), 80.1 (CH), 115.1 (CH), 127.3 (2 CH), 127.8 (CH),
2
3
2
J = 10.0 Hz, CH), 3.58 (1 H, dd, J = 11.7 Hz,
129.1 (2 CH), 129.9 (2 CH), 130.7 (2 CH), 131.4 (C),
3
J = 5.3 Hz, CH), 3.99–4.04 (1 H, m, CH), 4.56–4.61 (1
139.2 (C), 144.7 (C), 150.1 (C), 165.8 (C). EI‐MS (70 eV):
3
+
H, m, CH), 6.43 (1 H, s, CH), 7.30 (1 H, t, J = 7.6 Hz,
m/z (%) = 293 (M , 2), 278 (13), 202 (27), 175 (49), 112
3
CH), 7.45 (2 H, t, J = 7.6 Hz, 2 CH), 7.62 (2 H, d,
(62), 98 (87), 91 (34), 77 (100). Anal. Calcd (%) for
C H NO (293.37): C, 77.79; H, 6.53, N, 4.77. Found:
3
13
J = 7.6 Hz, 2 CH). C NMR (125.7 MHz, CDCl3):
δ = 20.3 (Me), 22.5 (2 Me), 51.1 (CH ), 60.6 (CH), 79.3
19
19
2
C, 77.96; H, 6.74, N, 4.93.
C
2